Member Info for tomvisual

Govt Loan Scheme payments due back in May 2021. Companies may be more inclined to join what Syme is offering to ehance cash flow.
Syme is positioned at the right place at the right time. Buy and hold for long term gains.

Lets see what today brings. Hopefully, we are at the start of something big. For me the Zak Mir interview will provide more scrutiny of my decision to be invested here.
Shares go up and down. Its part of the psychological games that the investment market plays. Invested for the long term here.
Agree with other holder comments, buy and hold.

Yesterday's drop is the MM extracting the most from fear and greed in new investors. You saw it also on SNG yesterday. LTH are waiting for the RNS to land. STH when they see the share price drop have to battle with the psychological thought that their investment decision was wrong.
SNG went up x5 on a study of 101 patients. From my research, the imbalance in patients with Diabetes and Cardio vascular disease in the SNG trial is concerning. More details need to be published about how corrections for baseline differences were made.
As everyone waits for news, this allows the MM to drop prices. Essentially, locking in newcomers. The perfect storm for psychological games!
Perhaps main difference with SNG is that Avacta share price has been held back for some time.
You will be rewarded by investing on Avacta.
DYOR research on SNG and visit their BB!
Test, test, test

Zak Mir has a target of 1.5p.
This was evaluated before the dicussion with AZ.
This is going one way according to my chart reading! Onwards and upwards

RNS. Use Red dot or https://www.investegate.co.uk/amigo-holdings-plc--amgo-/rns/response-to-social-media-speculation/202008240700088907W/

Daily Mail article
https://www.dailymail.co.uk/news/article-8656787/Blood-pressure-drug-cuts-Covid-death-risk-third.html

Covid-19 patients who have been prescribed the medication were 33 per cent less likely to die or be admitted to intensive care.
The drugs – Angiotensin-Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs) – are used to treat high blood pressure, heart attacks and diabetes.
33%..
35% with no placebo control was good for Trump last night.
Pity no one took AS up on developing the Avacta Affirmer ACE blocker!

PL75, great link on Convalescent Plasma snd the FDA initial thoughts.
*No placebo control
*Fauci blocker
*No Peer Review

https://m.youtube.com/watch?feature=youtu.be&v=pvmtT_XV4aw

Trump forcing the issue. Very dangerous!!
Last sentence... paper testing, 3M?

Test, test, test

Are ISA dividends free from tax?

On the numbers required, the LFT must create a major plastic waste problem
Any Company investment opportunities for plastic recycling that anyone is aware of that may lessen this issue? RichKen I recall you referencing a Company?

I think Trump may think there are several upsides:
* There may be a few really good and effective PoC or home tests that are just about through evaluation. When these are used in large quantity Trump can falsely claim that the success of these TESTS in controlling the epidemic is all down to him sidelining the FDA.
* Trump will use any successes due to the new tests as part of his campaign to blame the FDA for the failures to control Covid-19 in the US.

Weathergeek, can you please confirm your divi estimate per million shares held?

https://www.investegate.co.uk/supply--me-capital--syme-/rns/director-pdmr-shareholding/202008210700038092W/

https://www.investegate.co.uk/supply--me-capital--syme-/rns/holding-s--in-company/202008210700068093W/

Can someone post the GB tweet?
Looking at the DM article
a 'lovely test from the US' being brought in.
The device is a no larger than a teacup and plugs into a wall socket in order to read the sample of a swab taken from the nose or mouth.
Inside is technology called isothermal amplification, which helps to detect traces of the coronavirus' genetics.
Does not sound like our test!

Liquid1..
I think its in this link
https://www.share-talk.com/share-talk-bulletin-board-heroes-tuesday-18th-august-2020/#gs.dezofx
Listen to comments on syme

Good for staff.
Does this mean that no major rns news until after 26th August???

Yes. Could be a bubble and return to 0.5p. 1-1.1p was my target.
However, if II are buying on the back of PI selling out then the share price moves on.
Even Rolls Royce has a cash crisis, see https://www.telegraph.co.uk/business/2020/08/13/cash-crunch-just-another-crisis-rolls-royce/.
If inventory can be monetarised at the levels discussed then this can be a game changer.
As I had ASOS at 2p in my youth (> 20years ago, which I sold for peanuts), I have seen the importance if getting in early.
This may be a rollercoaster ride, but I am prepared for it!

Look at BRH. They 100% own Paraytec who are developing a 5 min covid test with Sheffield University. MC is £6M.
Most covid stocks get to £300M. Thats x50.
Test available in 3-4 weeks.

Global last seen on another board - syme.
Good luck to shareholders!

From the Fool article ...
"the Supply@ME Capital share price looks cheap based on its potential market"
Therefore have decided to invest here.

What are Medusa playing at?
Communications need to clear as we approach test availability! Focus must be on the main event.
Test, test, test